The same week, Congress passed the Project BioShield Act—which Kadlec also helped draft—launching the Biomedical Advanced Research and Development Authority (BARDA), a government-operated investment bank that would germinate new technologies for Kadlec’s stockpile. With Kadlec’s guidance, BARDA would become a federal ATM machine for Big Pharma, biodefense contractors, and gain-of-function researchers.
